JL
John M Leonard (President and CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Intellia Therapeutics, Inc. (NTLA). The largest single filing was $785K of NTLA (82,791 sh across 2 lots, as filed), executed Dec 11 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3
Median ADV $62.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
NTLARecent filings
NTLASALE
Intellia Therapeutics, Inc.
View filing →
$108K9,000 sh × $11.99
Exec Nov 2
Filed Nov 3 · 4:20 PM ET NTLASALE Intellia Therapeutics, Inc. View filing → $251K
19,890 sh × $12.60
Exec Aug 20
Filed Aug 24 · 4:05 PM ET NTLASALE Intellia Therapeutics, Inc. View filing → $314K
34,146 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NTLASALE Intellia Therapeutics, Inc. View filing → $785K
82,791 sh across 2 lots
Exec Dec 11 2025
Filed Dec 12 2025 · 5:30 PM ET NTLASALE Intellia Therapeutics, Inc. View filing → $327K
26,807 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET